Trial intelligence / Profile preview

Pharmacokinetic modelling of ropivacaine in plastic surgery

NL-OMON44042Not yet recruiting

Sponsor
Máxima Medisch Centrum
Start
May 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ropivacaine, sponsored by Máxima Medisch Centrum. Primary endpoints: Parameters influencing absorption of locally infiltrated ropivacaine, Venous serum concentration of ropivacaine over time and 1 more. Planned start May 2016; status: not yet recruiting.

02

Drugs

ropivacaine

Beyond the preview

Go deeper on NL-OMON44042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call